Evidence map›Paper›PMID 34667962›Full record

ArticleHeart rhythm O22021

Association of chronic kidney disease and end-stage renal disease with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: Insights from the national inpatient sample of 36,065 procedures.

Muhammad Bilal Munir, Muhammad Zia Khan, Douglas Darden, Marin Nishimura, Sai Vanam, Deepak Kumar Pasupula, Zain Ul Abideen Asad, Abhishek Bhagat, Salman Zahid, Mohammed Osman and 4 more

Open access · goldAbstract read
In one paragraph

Article in Heart rhythm O2, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Outcomes of left atrial appendage occlusion with atrial fibrillation ablation: a real-world analysis from the National Inpatient Sample database.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  9. Article
  10. Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  11. Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Muhammad Bilal MunirSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
Muhammad Zia KhanDivision of Cardiovascular Medicine, West Virginia University Heart & Vascular Institute, Morgantown, West Virginia.
Douglas DardenSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
Marin NishimuraSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
Sai VanamSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
Deepak Kumar PasupulaDivision of Cardiology, MercyOne North Iowa Medical Center, Mason City, Iowa.
Zain Ul Abideen AsadDivision of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Abhishek BhagatDivision of Cardiology, University of Arizona College of Medicine, Phoenix, Arizona.
Salman ZahidDepartment of Medicine, Rochester General Hospital, Rochester, New York.
Mohammed OsmanDivision of Cardiovascular Medicine, West Virginia University Heart & Vascular Institute, Morgantown, West Virginia.
Sudarshan BallaDivision of Cardiovascular Medicine, West Virginia University Heart & Vascular Institute, Morgantown, West Virginia.
Frederick T HanSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
Ryan ReevesSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
Jonathan C HsuSection of Electrophysiology, Division of Cardiology, University of California San Diego, La Jolla, California.
University of California, San Diego · USWest Virginia University · USMercy Medical Center · USRochester General Hospital · USUniversity of Arizona · USUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeft atrial appendage occlusion (LAAO) has emerged as an alternative strategy to oral anticoagulation for mitigating ischemic stroke risk in selected patients with atrial fibrillation (AF), but safety data in patients with significant kidney disease are limited.

objectiveTo determine the association of chronic kidney disease (CKD) and end-stage renal disease (ESRD) with procedural complications and in-hospital outcomes after LAAO in AF patients.

methodsData were extracted from National Inpatient Sample for calendar years 2015-2018. Watchman implantations were identified on the basis of International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes of 37.90 and 02L73DK. The outcomes assessed in our study included complications, inpatient mortality, and resource utilization with LAAO.

resultsA total of 36,065 Watchman recipients were included in the final analysis. CKD (9.8%, n = 3545) and ESRD (3%, n = 1155) were associated with a higher prevalence of major complications and mortality in crude analysis compared to no CKD. After multivariate adjustment for potential confounders, CKD was associated with length of stay (LOS) >1 day (adjusted odds ratio [aOR] 1.355; 95% confidence interval [CI] 1.234-1.488), median cost >$24,663 (aOR 1.267; 95% CI 1.176-1.365), and acute kidney injury (aOR 4.134; 95% CI 3.536-4.833), while ESRD was associated with in-patient mortality (aOR 7.156; 95% CI 3.294-15.544).

conclusionThe prevalence of CKD and ESRD was approximately 13% in AF patients undergoing Watchman LAAO implantations. CKD was independently associated with prolonged LOS, higher hospitalization costs, and acute kidney injury, while ESRD was independently associated with in-patient mortality.

Indexed as

Chronic kidney diseaseEnd-stage renal failureLeft atrial appendage occlusionOutcomesWatchman

Identifiers

PMID34667962
PMCPMC8505197
OpenAlexW3194077075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.